FI942184A0 - Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita - Google Patents

Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita

Info

Publication number
FI942184A0
FI942184A0 FI942184A FI942184A FI942184A0 FI 942184 A0 FI942184 A0 FI 942184A0 FI 942184 A FI942184 A FI 942184A FI 942184 A FI942184 A FI 942184A FI 942184 A0 FI942184 A0 FI 942184A0
Authority
FI
Finland
Prior art keywords
peptide
ebv
pct
peptides
antibodies
Prior art date
Application number
FI942184A
Other languages
English (en)
Swedish (sv)
Other versions
FI114781B (fi
FI942184A (fi
Inventor
Jaap Michiel Middeldorp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI942184A publication Critical patent/FI942184A/fi
Publication of FI942184A0 publication Critical patent/FI942184A0/fi
Application granted granted Critical
Publication of FI114781B publication Critical patent/FI114781B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI942184A 1992-09-14 1994-05-11 Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita FI114781B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92202797 1992-09-14
EP92202797 1992-09-14
PCT/EP1993/002478 WO1994006912A1 (en) 1992-09-14 1993-09-13 Epstein-barr virus peptides and antibodies against these peptides
EP9302478 1993-09-13

Publications (3)

Publication Number Publication Date
FI942184A FI942184A (fi) 1994-05-11
FI942184A0 true FI942184A0 (fi) 1994-05-11
FI114781B FI114781B (fi) 2004-12-31

Family

ID=8210912

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942184A FI114781B (fi) 1992-09-14 1994-05-11 Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita

Country Status (13)

Country Link
US (1) US5965353A (fi)
EP (1) EP0607425B1 (fi)
JP (3) JP4155591B2 (fi)
KR (1) KR100384250B1 (fi)
AT (1) ATE266728T1 (fi)
AU (1) AU667745B2 (fi)
CA (1) CA2120342C (fi)
DE (1) DE69333511T2 (fi)
DK (1) DK0607425T3 (fi)
ES (1) ES2221922T3 (fi)
FI (1) FI114781B (fi)
HK (1) HK1001461A1 (fi)
WO (1) WO1994006912A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
WO1996002563A1 (en) * 1994-07-13 1996-02-01 Cornell Research Foundation, Inc. Epstein-barr virus nuclear antigen 1 protein and its expression and recovery
AU766165B2 (en) * 1997-01-13 2003-10-09 Oklahoma Medical Research Foundation Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
ITMI20010445A1 (it) 2001-03-05 2002-09-05 Enitecnologie Spa Dispersioni acquose di residui petroliferi pesanti
WO2004007536A2 (en) * 2002-07-16 2004-01-22 Affinium Pharmaceuticals, Inc. Interactions of the epstein-barr virus protein ebna1, and uses thereof
WO2022146869A1 (en) * 2020-12-29 2022-07-07 The Board Of Trustees Of The Leland Stanford Junior University Diagnostics and therapeutics for ebv in ms and other autoimmune diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5717065A (en) * 1984-08-08 1998-02-10 The Scripps Research Institute Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット

Also Published As

Publication number Publication date
EP0607425A1 (en) 1994-07-27
US5965353A (en) 1999-10-12
AU667745B2 (en) 1996-04-04
ATE266728T1 (de) 2004-05-15
DE69333511D1 (de) 2004-06-17
FI114781B (fi) 2004-12-31
KR100384250B1 (ko) 2003-12-24
CA2120342A1 (en) 1994-03-31
FI942184A (fi) 1994-05-11
WO1994006912A1 (en) 1994-03-31
JP2008273972A (ja) 2008-11-13
HK1001461A1 (en) 1998-06-19
CA2120342C (en) 2004-11-16
ES2221922T3 (es) 2005-01-16
JP4155591B2 (ja) 2008-09-24
DK0607425T3 (da) 2004-09-20
JP2009280589A (ja) 2009-12-03
JP4368406B2 (ja) 2009-11-18
JPH07501710A (ja) 1995-02-23
AU4816293A (en) 1994-04-12
JP4957974B2 (ja) 2012-06-20
EP0607425B1 (en) 2004-05-12
DE69333511T2 (de) 2005-05-12

Similar Documents

Publication Publication Date Title
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
HUP0103650A2 (hu) Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására
EP1318401A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
EP0769696A3 (en) Antibodies and proteins useful for assaying virus infection in grape plants
ID19063A (id) Pereaksi peptida untuk deteksi cytomegalovirus (cmv)
ZA964683B (en) Epstein-barr virus peptides and antibodies against these peptides
FI942184A (fi) Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
FI103975B1 (fi) Immunodiagnostinen nivelreumakoe
ATE189683T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE69534263D1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
RU2000124671A (ru) Эпитопы в белках вирусной оболочки и специфические антитела, направленные против этих эпитопов: применение для обнаружения антигена вируса hcv в ткани хозяина
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
IT1250367B (it) Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.

Legal Events

Date Code Title Description
MA Patent expired